Negotiated drug prices would force LTC pharmacists out of business, cost taxpayers billions, coalition says
By Kathleen Steele Gaivin | McKnight’s Senior Living
If Congress does not pass proposed legislation to address the cost to long-term pharmacies related to negotiated drug prices, it could cost taxpayers up to $4.8 billion in increased healthcare costs over the next decade, the Senior Care Pharmacy Coalition said this week.
The Preserving Patient Access to Long-Term Pharmacies Act, first put forth in August, would establish a $30 supply fee per Medicare Part D prescription in 2026 and 2027, although the proposed fee could increase in 2027 due to inflation.
“Long-term care pharmacies are a lifeline for millions of seniors and their families,” Rep. Beth Van Duyne (R-TX) said in a statement earlier this year. “If we fail to act before Jan. 1, 2026, many of these pharmacies will be forced to close their doors, leaving nursing homes, assisted living facilities, and vulnerable patients without the care they rely on.”
Van Duyne called the legislation a “critical fix” that would allow long-term care pharmacies to continue.
The negotiated prices threaten the pharmacies because they differ from retail pharmacies and “must dispense drugs in special packaging, provide expert consultant services including medication management, and provide 24/7/365 prescription drugs and services to patients in LTC facilities,” SCPC said.
According to SCPC, the average long-term care pharmacy resident or patient takes 13 different prescription medications.
Sixty percent of nursing home and assisted living operators will close their pharmacies next year if the bill is not passed, 90% will lay off staff members and 80% will have to reduce services and increase charges to facilities and residents in 2026, according to the coalition.
“Without this LTC pharmacy fix, patients in nursing homes will lose access to essential drugs and LTC pharmacy services and federal spending will increase more than the cost of fixing the problem,” SCPC President and CEO Alan Rosenbloom said. “Congress must pass the Preserving Patient Access to Long-Term Care Pharmacies Act now. It would be a win for patients, LTC facilities and pharmacies, and American taxpayers.”
Read the full article on the McKnight’s Senior Living here
Recent Posts
-
SCPC Submits Second Round of Comments to Healthcare Advisory Committee
The Senior Care Pharmacy Coalition submitted comments yesterday to the Healthcare Advisory Committee (HAC). The HAC is a group of experts charged with delivering strategic recommendations directly to the HHS Secretary and CMS Administrator to improve how care is financed and delivered across Medicare, Medicaid and the Children’s Health Insurance Program (CHIP), and the Health […]
-
SCPC Responds to Senate Finance Committee Request for Information on Commonsense Policy Options to Lower Drug Prices for Patients
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, submitted comments to the Senate Finance Committee’s Request for Information (RFI) seeking input on commonsense policy options to lower drug prices for patients. “SCPC supports the Committee’s focus on reducing prescription drug costs while preserving beneficiary access and […]
-
LTC pharmacies said this would happen. New data says they were right.
By Donna Shryer // Published July 18, 2026 in McKnight’s Long-Term Care News Long-term care pharmacies predicted a steep reimbursement hit from the Inflation Reduction Act’s Medicare drug pricing changes. Now they say they have the data confirming it. A new analysis of member financial data shows reimbursement for drugs subject to the law’s negotiated […]
Stay Connected
Get the latest news and updates on issues impacting the long-term care pharmacy community.